LIFEVANTAGE CORP Share Repurchase Authorization
LIFEVANTAGE CORP (LFVN) had Share Repurchase Authorization of $60.00 million as of 2026-01-31, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-08-27
- 2026-01-31: Stock Repurchase Program Authorized Amount1 $60.00M.
- 2022-02-17: Stock Repurchase Program Authorized Amount1 $60.00M.
- 2022-02-16: Stock Repurchase Program Authorized Amount1 $35.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2026-01-31 | $60.00M 10-K · filed 2026-08-27 |
| 2022-02-17 | $60.00M 10-Q · filed 2026-02-04 |
| 2022-02-16 | $35.00M 10-Q · filed 2026-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |